Cell Metabolism and Myc induced growth, death, and neoplasia
Cell Metabolism and Myc induced growth, death, and neoplasia
批准号:
7363649
负责人:
DAVID M. HOCKENBERY
金额:
$28.72万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-02-28
关键词:
AllelesApoptosisApoptoticBindingBiochemical PathwayBioenergeticsBiological AssayBiologyCarbonCell CycleCell DeathCell ProliferationCell SurvivalCell modelCellsCessation of lifeCitric Acid CycleClassificationComparative StudyConditionCoupledDNA Sequencing FacilityDataData SetDevelopmentDominant-Negative MutationDrug Delivery SystemsDrug DesignEnergy MetabolismEnergy Metabolism PathwayEnzyme GeneEnzymesEventFoundationsFutureGene Expression RegulationGene ProteinsGenerationsGenesGenomicsGlycolysisGoalsGrowthHumanIn VitroInterventionLeadLinkLiteratureMalignant NeoplasmsMembrane PotentialsMetabolicMetabolic PathwayMetabolismMethodsMicroarray AnalysisMitochondriaModelingModificationMusNeoplasmsNeoplastic Cell TransformationOncogenesOncogenicOutcomeOxidative PhosphorylationOxygen ConsumptionPancreasPathway interactionsPhysiologicalPlayProliferatingPropertyProteomicsPublishingReactive Oxygen SpeciesRegulationResearchResearch PersonnelRoleStimulusStudy SectionTestingTherapeuticTissuesTranscription Factor OncogeneTranscriptional ActivationTransgenic MiceTransgenic OrganismsTumor Suppressor GenesUp-RegulationWorkbasec-myc Genescancer cellcell growthdrug developmentglucose metabolismin vivoinnovationinsightmetabolic abnormality assessmentnovelnrf1 proteinnuclear respiratory factorprogramspromotertranscription factortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The oncogene c-Myc is known to be involved in the development of many human cancers. Genomics and proteomics have identified many potential c-Myc targets involved in cell metabolism. Functional studies have shown that genes involved in glucose metabolism are regulated by c-Myc and our recent work provides evidence for Myc's involvement in oxidative phosphorylation (OXPHOS). However, the functional impact of Myc's regulation of metabolic genes has not been thoroughly investigated. Currently, the metabolic pathways essential for Myc-induced cancers are unknown and cannot be targeted for drug intervention. The first goal of this proposal is to generate metabolic profiles for Myc expressing cells under conditions where Myc induces growth, death or neoplasia in vivo and in vitro. The result generated from these studies will facilitate the identification of key points of intervention in metabolic pathways linked to Myc-induced neoplasia. A second goal is to identify Myc-induced genes involved in apoptosis and transformation. Knowing the identity of these genes will enable future studies to develop methods that induce apoptosis or disable transformation in Myc expressing cancer cells. The specific aims of this proposal include: 1) to determine how Myc's ability to control glucose metabolism and OXPHOS influences the flow of carbon metabolites through glycolysis and the TCA cycle under conditions that are conducive to growth, death or neoplasia and 2) to identify and characterize genes that are involved in Myc-induced apoptosis and transformation. The studies in this proposal utilize tissue specific, inducible transgenic mouse and cell models to understand the changes in energy metabolism that occur on up-regulation of c-Myc. These studies will involve an analysis of carbon flow and metabolic flux using 13C NMR and isotopomer analysis. Mitochondrial metabolism will be evaluated by oxygen consumption, OXPHOS enzyme assays, membrane potential and reactive oxygen species generation. Carbon metabolism is essential to cell survival and proliferation and we would expect that our metabolic approach would provide a greater understanding of the metabolic events underlying c-Myc induced neoplastic transformation and thereby provide novel target for cancer therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer
-
批准号:10603025
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2017
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8239473
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8464027
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8624665
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression
-
批准号:8838733
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2012
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8336879
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8218308
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8691819
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
-
批准号:8484404
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2011
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Metabolic alterations in advanced Breast Cancer and response to systemic therapy.
-
批准号:8181511
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2010
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Mechanisms linking Nutrient supply & cell cycle/survival
-
批准号:7737152
-
项目类别:
-
资助金额:$25.12万
-
财政年份:2008
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Regulation of substrate-linked mitochondrial ROS generation
-
批准号:7030016
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2006
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Regulation of substrate-linked mitochondrial ROS generation
-
批准号:7282707
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2006
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism & Myc induced growth, death, & neoplasia
-
批准号:6867657
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism & Myc induced growth death, & neoplasia
-
批准号:7017097
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism and Myc induced growth, death, and neoplasia
-
批准号:7216332
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Cell Metabolism and Myc induced growth, death, and neoplasia
-
批准号:7578931
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2005
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6634048
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6753499
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
Small Molecule Inhibitors of BcI xL Survival Protein
-
批准号:6515083
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2001
-
负责人:DAVID M. HOCKENBERY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: